Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Meissa Vaccines

    Client Virtual Booth

    MEISSA VACCINES

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Meissa Vaccines
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    JLABS, 329 Oyster Point Boulevard, 3rd Floor South San Francisco, CA 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.meissavaccines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/meissa-vaccines/
    Twitter
    Twitter
    https://twitter.com/meissavaccines

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Layoffs at Meissa Vaccines as biotech's future lies in limbo
    Layoffs at Meissa Vaccines as biotech's future lies in limbo

    https://www.fiercebiotech.com/biotech/meissa-vaccines-future-limbo-due-current-fundraising-climate-ceo

    FIERCE BIOTECH
    05 Mar 2024
    Share Share
    Meissa Vaccines Announces Positive Clinical Data for the First RSV Vaccine
    Meissa Vaccines Announces Positive Clinical Data for the First RSV Vaccine

    https://www.businesswire.com/news/home/20230808124808/en

    BUSINESSWIRE
    08 Aug 2023
    Share Share
    Meissa Vaccines Enters into cGMP Manufacturing Agreement for Pediatric RSV Vaccine Candidate for Phase 2 Clinical Trials
    Meissa Vaccines Enters into cGMP Manufacturing Agreement for Pediatric RSV Vaccine Candidate for Phase 2 Clinical Trials

    https://exothera.world/meissa-vaccines-enters-into-cgmp-manufacturing-agreement-for-pediatric-rsv-vaccine-candidate-for-phase-2-clinical-trials/

    PRESS RELEASE
    28 Jun 2023
    Share Share
    Meissa Vaccines Announces Positive Data for Intranasal Live Attenuated RSV
    Meissa Vaccines Announces Positive Data for Intranasal Live Attenuated RSV

    https://www.businesswire.com/news/home/20221107005432/en

    BUSINESSWIRE
    07 Nov 2022
    Share Share
    Meissa Presented at The White House Summit on Future of COVID-19 Vaccines
    Meissa Presented at The White House Summit on Future of COVID-19 Vaccines

    https://www.businesswire.com/news/home/20220726006074/en

    BUSINESSWIRE
    27 Jul 2022
    Share Share
    Meissa Vaccines Appoints Frank Glavin Chief Executive Officer
    Meissa Vaccines Appoints Frank Glavin Chief Executive Officer

    https://www.businesswire.com/news/home/20220711005060/en

    BUSINESSWIRE
    11 Jul 2022
    Share Share
    Meissa Announces Positive Preliminary Clinical Data on Safety and Immunogenicity
    Meissa Announces Positive Preliminary Clinical Data on Safety and Immunogenicity

    https://www.businesswire.com/news/home/20211028005281/en/Meissa-Announces-Positive-Preliminary-Clinical-Data-on-Safety-and-Immunogenicity-of-Intranasal-COVID-19-Vaccine

    BUSINESSWIRE
    28 Oct 2021
    Share Share
    Meissa Announces Preclinical Data on Intranasal COVID-19 Vaccine
    Meissa Announces Preclinical Data on Intranasal COVID-19 Vaccine

    https://www.businesswire.com/news/home/20210719005854/en

    BUSINESSWIRE
    20 Jul 2021
    Share Share
    Meissa Announces Preclinical Data on Intranasal COVID-19 Vaccine
    Meissa Announces Preclinical Data on Intranasal COVID-19 Vaccine

    https://www.businesswire.com/news/home/20210719005854/en

    BUSINESSWIRE
    19 Jul 2021
    Share Share
    Meissa Announces IND Clearance for Phase 1 Study of Intranasal Live
    Meissa Announces IND Clearance for Phase 1 Study of Intranasal Live

    https://pipelinereview.com/index.php/2021031677654/Vaccines/Meissa-Announces-IND-Clearance-for-Phase-1-Study-of-Intranasal-Live-Attenuated-Vaccine-Candidate-for-COVID-19.html

    PIPELINEREVIEW
    16 Mar 2021
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search